Brief: Neurelis Enters $208 Million Agreement To Monetize Intravail Royalties
14/11/2024 14:02
Nov 14 (Reuters) - ARS Pharmaceuticals Inc SPRY.O :
* NEURELIS ENTERS $208 MILLION AGREEMENT TO MONETIZE
INTRAVAIL
ROYALTIES
Source text: ID:nPn14yZjwa
Further company coverage: SPRY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ARS Pharmaceuticals
See all newsARS Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
ARS Pharmaceuticals Q2 neffy revenue rises as epinephrine market share doubles
U.S. STOCKS ON THE MOVE-Bumble, Tempus AI, TD Synnex
U.S. STOCKS ON THE MOVE-Bio-Techne, IBM, Apple
ARS Pharma tumbles as allergy nasal spray faces insurance coverage hurdle